Detalles de la búsqueda
1.
Anti-citrullinated protein antibody profiles predict changes in disease activity in patients with rheumatoid arthritis initiating biologics.
Rheumatology (Oxford);
63(2): 542-550, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37252826
2.
Treatment Patterns and Effectiveness of Tofacitinib in Patients Initiating Therapy for Rheumatoid Arthritis: Results From the CorEvitas Rheumatoid Arthritis Registry.
J Rheumatol;
51(5): 452-461, 2024 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38359941
3.
Meaningful Improvement and Worsening in Patients Who Do Not Achieve Low Disease Activity and Switch Therapy to a New Biologic or Targeted Disease-Modifying Antirheumatic Drug: Results From the CorEvitas RA Registry.
J Clin Rheumatol;
29(4): e47-e51, 2023 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37000177
4.
Assessing predictors of rheumatoid arthritis-associated interstitial lung disease using quantitative lung densitometry.
Rheumatology (Oxford);
61(7): 2792-2804, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34747452
5.
Perspectives on applying immuno-autonomics to rheumatoid arthritis: results from an online rheumatologist survey.
Rheumatol Int;
42(9): 1555-1564, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35449236
6.
Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis.
Ann Rheum Dis;
80(12): 1522-1529, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215644
7.
Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study.
Ann Rheum Dis;
80(1): 96-102, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32719038
8.
Variable blood processing procedures contribute to plasma proteomic variability.
Clin Proteomics;
18(1): 5, 2021 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33468058
9.
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data.
Rheumatol Int;
41(2): 381-390, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32876744
10.
Perceived clinical utility of a test for predicting inadequate response to TNF inhibitor therapies in rheumatoid arthritis: results from a decision impact study.
Rheumatol Int;
41(3): 585-593, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33258003
11.
Genetics of rheumatoid arthritis contributes to biology and drug discovery.
Nature;
506(7488): 376-81, 2014 Feb 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-24390342
12.
Adjustment of the multi-biomarker disease activity score to account for age, sex and adiposity in patients with rheumatoid arthritis.
Rheumatology (Oxford);
58(5): 874-883, 2019 05 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30590790
13.
Design characteristics of the Corrona Japan rheumatoid arthritis registry.
Mod Rheumatol;
28(1): 95-100, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28448195
14.
Response to 'Correspondence on 'Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with rheumatoid arthritis: results from a large US registry study'' by Zheng et al.
Ann Rheum Dis;
81(11): e225, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33177102
15.
Age-based (<65 vs ≥65 years) incidence of infections and serious infections with tofacitinib versus biological DMARDs in rheumatoid arthritis clinical trials and the US Corrona RA registry.
Ann Rheum Dis;
80(1): 134-136, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33046447
16.
How comparable are rates of malignancies in patients with rheumatoid arthritis across the world? A comparison of cancer rates, and means to optimise their comparability, in five RA registries.
Ann Rheum Dis;
75(10): 1789-96, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26621482
17.
Can rheumatoid arthritis (RA) registries provide contextual safety data for modern RA clinical trials? The case for mortality and cardiovascular disease.
Ann Rheum Dis;
75(10): 1797-805, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26857699
18.
A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk.
Ann Rheum Dis;
74(1): 170-6, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24092415
19.
High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci.
Ann Rheum Dis;
74(3): e13, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24532676
20.
Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
Pharmacoepidemiol Drug Saf;
24(11): 1121-32, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26303866